Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Dietary bioactive ingredients to modulate the gut microbiota derived metabolite TMAO. New opportunities for functional food development Food & Function (RSC Publishing) DOI:10.1039 D0FO01237H Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link